scispace - formally typeset
C

Cristina Varas-Lorenzo

Researcher at Pfizer

Publications -  36
Citations -  2895

Cristina Varas-Lorenzo is an academic researcher from Pfizer. The author has contributed to research in topics: Population & Cohort study. The author has an hindex of 20, co-authored 36 publications receiving 2555 citations. Previous affiliations of Cristina Varas-Lorenzo include Novartis.

Papers
More filters
Journal ArticleDOI

Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa Scale and the RTI item bank

Andrea V. Margulis, +7 more
- 10 Oct 2014 - 
TL;DR: The RTI-IB facilitates a more complete quality assessment than the NOS but is more burdensome; the observed agreement and AC1 statistic in this study were higher than those reported by the RTI’s developers.
Journal ArticleDOI

Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population.

Consuelo Huerta, +3 more
- 01 Mar 2005 - 
TL;DR: NSAID users had a 3-fold greater risk for developing a first-ever diagnosis of clinical ARF compared with non-NSAIDs users in the general population, and NSAIDs should be used with special caution in patients with hypertension and/or HF.
Journal ArticleDOI

Individual NSAIDs and Upper Gastrointestinal Complications: A Systematic Review and Meta-Analysis of Observational Studies (the SOS Project)

Jordi Castellsague, +7 more
- 01 Dec 2012 - 
TL;DR: In this article, the authors conducted a systematic review and meta-analysis of observational studies to provide summary relative risks (RR) of upper GI complications associated with the use of individual NSAIDs, including selective cyclooxygenase-2 inhibitors.
Journal ArticleDOI

Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population

Luis A. García Rodríguez, +3 more
- 22 Jun 2004 - 
TL;DR: The results do not support the existence of a clinically meaningful interaction between aspirin and NSAIDs, including ibuprofen, including aspirin taken concomitantly.
Journal ArticleDOI

Individual NSAIDs and Upper Gastrointestinal Complications

Jordi Castellsague, +7 more
- 13 Dec 2012 - 
TL;DR: In this paper, the authors conducted a systematic review and meta-analysis of observational studies to provide summary relative risks (RR) of upper GI complications (UGIC) associated with the use of individual NSAIDs, including selective cyclooxygenase-2 inhibitors.